<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23926236</PMID>
<DateCompleted>
<Year>2014</Year>
<Month>03</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2016</Year>
<Month>11</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1600-0455</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>55</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Acta radiologica (Stockholm, Sweden : 1987)</Title>
<ISOAbbreviation>Acta Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Lymphoscintigraphy with peritumoral injection versus lymphoscintigraphy with subdermal periareolar injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.</ArticleTitle>
<Pagination>
<MedlinePgn>39-44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1177/0284185113493775</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Preoperative lymphoscintigraphy is without doubt a valid method for the detection of the sentinel lymph node (SLN). There has been considerable debate regarding the optimal site for the introduction of the tracer; various sites include peritumoral (PT), periareolar (PA), subdermal, and intradermal injection.</AbstractText>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate retrospectively the lymphoscintigraphic identification rate of peritumoral (PT) injection versus subdermal periareolar (PA) injection in the detection of SLNs in breast cancer.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Between October 2002 and December 2011, a cohort of 906 consecutive patients with biopsy proven breast cancer underwent 914 SLN biopsy procedures. A total of 339 procedures (Group A) were performed using a PT deep injection of radiotracer while 575 procedures (Group B) adopted a subdermal PA injection of radiotracer towards the upper outer quadrant, regardless of the site of the carcinoma. All the patients underwent synchronous excision of the breast cancer and SLN biopsy.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">SLNs were identified in the lymphoscintigram in 308/339 cases (90.85%) of Group A (PT injection) and in 537/575 cases (93.39%) of Group B (PA injection). Furthermore, in 2/339 patients (0.58%) of Group A, internal mammary lymph nodes were found at lymphoscintigraphy, whereas no internal mammary sentinel nodes were found in the Group B patients. The intraoperative identification rate of axillary SLNs was 99.41% (337 of 339) in the Group A patients and 99.65% (573 of 575) in the Group B patients. There was no significant difference in the two groups between the incidence of the number of SLNs detected and the incidence of identification of positive SLNs.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">PT versus PA injection of radiotracer showed comparable success rates for axillary SLN identification, and can be considered a rapid and reliable method.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Caruso</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Biotechnologies and Forensic Medicine - Section of Radiological Sciences, AOU Policlinico Paolo Giaccone - University of Palermo, Palermo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cipolla</LastName>
<ForeName>Calogero</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Costa</LastName>
<ForeName>Renato</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Morabito</LastName>
<ForeName>Alessandra</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Latteri</LastName>
<ForeName>Stefania</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fricano</LastName>
<ForeName>Salvatore</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Salerno</LastName>
<ForeName>Sergio</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Latteri</LastName>
<ForeName>Mario Adelfio</ForeName>
<Initials>MA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>08</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Acta Radiol</MedlineTA>
<NlmUniqueID>8706123</NlmUniqueID>
<ISSNLinking>0284-1851</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013668">Technetium Tc 99m Aggregated Albumin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C083602">technetium Tc 99m nanocolloid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000000981">diagnostic imaging</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015552">Injections, Intralesional</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D061305">Lymphoscintigraphy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019275">Radiopharmaceuticals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D021701">Sentinel Lymph Node Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013668">Technetium Tc 99m Aggregated Albumin</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Breast cancer</Keyword>
<Keyword MajorTopicYN="N">lymphoscintigraphy</Keyword>
<Keyword MajorTopicYN="N">peritumoral</Keyword>
<Keyword MajorTopicYN="N">radio-colloid</Keyword>
<Keyword MajorTopicYN="N">sentinel lymph node biopsy</Keyword>
<Keyword MajorTopicYN="N">sub areolar</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>8</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>8</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>3</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">23926236</ArticleId>
<ArticleId IdType="pii">0284185113493775</ArticleId>
<ArticleId IdType="doi">10.1177/0284185113493775</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>